613 Neoadjuvant SEMA4D blockade with nivolumab alters suppressive myeloid cells while elevating B cell and CD26hiT cell infiltration in the tumors of patients with resectable stage III melanoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.